1. Circulation. 2020 Jan 28;141(4):e57-e58. doi:
10.1161/CIRCULATIONAHA.119.044819.  Epub 2020 Jan 27.

Response by Bergmark et al to Letter Regarding Article, "Metformin Use and 
Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart 
Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".

Bergmark BA(1), Bhatt DL(1), McGuire DK(2), Scirica BM(1).

Author information:
(1)Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular 
Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 
(B.A.B., D.L.B., B.M.S.).
(2)Division of Cardiology, Department of Internal Medicine, University of Texas 
Southwestern Medical Center, Dallas (D.K.M.).

Comment on
    Circulation. 2019 Sep 17;140(12):1004-1014.
    Circulation. 2020 Jan 28;141(4):e55-e56.

DOI: 10.1161/CIRCULATIONAHA.119.044819
PMID: 31986098 [Indexed for MEDLINE]
